Methyl Methanesulfonate. Dimethylsulfonate . Mesilate, Methyl . Methyl Mesylate . Methyl Methylenesulfonate . Methylmesilate . Mesylate, Methyl . Methanesulfonate, Methyl . Methyl Mesilate . Methylmethane Sulfonate . An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. . 0.76
Ethyl Methanesulfonate. Ethyl Mesilate . Ethyl Mesylate . Ethylmesilate . Ethylmesylate . Mesilate, Ethyl . Mesylate, Ethyl . Methanesulfonate, Ethyl . Sulfonate, Ethylmethane . Ethylmethane Sulfonate . An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect. . 0.74
Gabexate. Foy 18246 . Gabexate Mesilate . Gabexate Mesylate . Gabexate Methanesulfonate . Gabexate Monomethanesulfonate . Gabexate Monomethanesulfonate, 14C-Labeled Cpd . Gabexate Monomethanesulfonate, 14C Labeled Cpd . Mesilate, Gabexate . Mesylate, Gabexate . Methanesulfonate, Gabexate . Monomethanesulfonate, Gabexate . A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. . 0.64